EPISODE · Oct 21, 2024 · 10 MIN
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
from JACC This Week
In this episode, Dr. David J. Schneider research identifies platelet FCγRIIA (PFCG) as a key biomarker for cardiovascular risk post-myocardial infarction. In an 800-patient study, higher PFCG levels were linked to increased risks of myocardial infarction, stroke, and death, indicating its potential for guiding personalized antiplatelet therapy, pending further validation.
NOW PLAYING
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m